The gel it forms softens stool without adding excessive bulk, which matters when your system is already processing food more slowly
This soluble fiber absorbs water and expands significantly, creating bulk that promotes movement without irritation
Cardiovascular outcomes trials such as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown that certain GLP-1 receptor agonists significantly reduce major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors
However people with low homocysteine, mostly don't have these negative reactions to taking B12 as an injection or oral
Glippy Glippy a free glp-1 shot tracking app available on IOS ( App Store Link )
Most customers report noticing a difference within two to four weeks of consistent daily use, with more pronounced results developing over 60 to 90 days